What is Modulim?
Modulim is a pioneer in optical imaging solutions, leveraging spatial frequency domain imaging (SFDI) technology to provide clinicians with critical insights into compromised circulation. This innovative approach aims to enhance diagnostic capabilities and improve patient outcomes in various medical applications. The company's focus on developing advanced imaging tools positions it as a key player in the medtech landscape, attracting substantial enterprise-level funding.
How much funding has Modulim raised?
Modulim has raised a total of $12.7M across 5 funding rounds:
Angel/Seed
$500K
Private Equity
$2M
Series A
$2.9M
Series B
$7M
Debt
$350K
Angel/Seed (2016): $500K with participation from The Cove Fund
Private Equity (2017): $2M, investors not publicly disclosed
Series A (2017): $2.9M supported by Hamamatsu, Mitsubishi UFJ Capital Co, Ltd, and Grey Sky Venture Partners
Series B (2019): $7M, investors not publicly disclosed
Debt (2020): $350K backed by PPP
Key Investors in Modulim
The Cove Fund
The Cove Fund, associated with Cove Financial Group, focuses on innovative financial solutions, particularly in real estate, aiming to transform home ownership and provide stability for families. Their involvement suggests an interest in companies with tangible, impactful applications.
Hamamatsu
Hamamatsu Photonics is a global leader in photonics technology, providing advanced imaging sensors and optical systems for medical, scientific, and industrial applications. Their investment indicates a strategic alignment with Modulim's optical imaging advancements.
Mitsubishi UFJ Capital Co, Ltd
Mitsubishi UFJ Capital Co, Ltd is a venture capital firm with deep expertise in supporting companies targeting the Japanese market and facilitating international investment. Their participation highlights a global perspective on Modulim's growth potential.
What's next for Modulim?
With the recent infusion of capital, Modulim is poised for significant expansion and further development of its proprietary SFDI technology. This strategic investment will likely fuel advancements in product refinement, market penetration, and the scaling of operations. The company's trajectory suggests a focus on solidifying its market position and potentially exploring new clinical applications for its imaging solutions, marking a critical phase in its growth.
See full Modulim company page
